<html>
<head>PUBMED IDs for CSPG4</head>
<body bgcolor='#C5F0F2'><h1>CSPG4</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18317448/'>Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19130216/'>Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation.</a> July 7  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21658254/'>Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.</a> May 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21717063/'>The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells.</a> November 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21802410/'>Differential PAX3 functions in normal skin melanocytes and melanoma cells.</a> October 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21829586/'>Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21829582/'>Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21863242/'>Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.</a> July 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22893632/'>CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.</a> May 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22984505/'>FH535 inhibited migration and growth of breast cancer cells.</a> March 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22984501/'>Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010.</a> March 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22984500/'>Association of single nucleotide polymorphisms of IL23R and IL17 with ulcerative colitis risk in a Chinese Han population.</a> March 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24386429/'>Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24386425/'>Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24386414/'>Extracellular HSP70/HSP70-PCs promote epithelial-mesenchymal transition of hepatocarcinoma cells.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24386413/'>Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24740185/'>Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24969320/'>Antibody therapies for melanoma: new and emerging opportunities to activate immunity (Review).</a> November 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25069475/'>Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.</a> September 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25268630/'>Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma.</a> June 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25547119/'>Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.</a> April 19  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25706398/'>Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blasts.</a> February 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25935541/'>Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.</a> February 18  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25997619/'>Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.</a> March 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25997618/'>The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.</a> February 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27037627/'>A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.</a> April 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28011196/'>Isolating subpopulations of human epidermal basal cells based on polyclonal serum against trypsin-resistant CSPG4 epitopes.</a> December 25  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28098860/'>Chondroitin sulfate proteoglycan protein is stimulated by interleukinÂ 11 and promotes endometrial epithelial cancer cell proliferation and migration.</a> January 19  2017<br></body></html>
